Vaccine News and Research

Latest Vaccine News and Research

Cell surface marker CD47 may allow early diagnosis of severe COVID-19

A new study reports the potential of the cell surface marker, CD47, as a biomarker for hyperinflammation, a characteristic feature of severe COVID-19.

4 Mar 2021

Researchers detect vaccine-induced SARS-CoV-2 antibodies in breast milk

A new paper released on the medRxiv* preprint server describes, for the first time, the detection of antibodies to the virus in human breast milk following the vaccination of lactating mothers. This could guide patients, their healthcare providers, and public health policymakers alike as to the deployment of the vaccines in pregnant and lactating mothers.

4 Mar 2021

Reopening of long-term care facilities is ‘an absolute necessity for our well-being’

For nearly a year, nursing homes and assisted living centers have been mostly closed to visitors. Now, it's time for them to open back up and relieve residents of crushing isolation, according to a growing chorus of long-term care experts, caregivers, consumer groups and physicians.

4 Mar 2021

Coronavirus deranges the immune system in complex and deadly ways

There's a reason soldiers go through basic training before heading into combat: Without careful instruction, green recruits armed with powerful weapons could be as dangerous to one another as to the enemy.

4 Mar 2021

To help farmworkers get Covid tests and vaccine, build trust and a safety net

With more than 20 million acres of corn and soybeans, Illinois is among the top U.S. producers of those crops. To make it all happen, the state relies on thousands of farmworkers — some of whom travel to the state for seasonal work and others, like 35-year-old Saraí, who call Illinois home.

4 Mar 2021

Accidentally trashed, thawed or expired: reports of Covid vaccine spoilage

As the speed of covid vaccinations picks up, so do the reports of doses going to waste. And it’s more than just a handful at the end of the day because of a few appointment cancellations. Health officials are trying to rein in waste without slowing down vaccinations.

4 Mar 2021

Research looks at COVID vaccine hesitancy and refusal among the U.S. public

Vaccination against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rolled out in many countries, including the United States. As the number of coronavirus disease (COVID-19) cases continues to rise, vaccinating many people in the population is crucial. Despite campaigns to inform residents of the benefits of vaccines, many are still reluctant to get vaccinated.

4 Mar 2021

Mask wearing, physical distancing can prevent spikes in COVID-19 cases during vaccine distribution

Research out on the pre-publication website medRxiv shows how non-pharmaceutical interventions (NPIs) like mask wearing and physical distancing can help prevent spikes in COVID-19 cases as populations continue to get vaccinated.

4 Mar 2021

Researchers call for more awareness relating to delayed skin reactions to Moderna COVID-19 vaccine

As the speed and scale of vaccinations against the SARS-CoV-2 virus ramps up globally, researchers at Massachusetts General Hospital (MGH) are calling for greater awareness and communication around a delayed injection-site reaction that can occur in some patients who have received the Moderna mRNA-1273 vaccine.

3 Mar 2021

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Researchers from California in the United States have conducted a study showing that important adaptive immune responses to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not affected by four recently emerged variants of the virus.

3 Mar 2021

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant

In a recent research paper currently available on the bioRxiv* preprint server, a diverse group of researchers has examined the immunogenicity of antibodies against the variant B.1.1.7 of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) initially found in the United Kingdom – and revealed diminished recognition and neutralization of either parental strains or the South African variant.

3 Mar 2021

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Novavax, Inc., the American vaccine development company, has been developing a recombinant protein nanoparticle COVID-19 vaccine currently termed NVX-CoV2373. The full-length spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is created in a baculovirus vector, which is then inserted into a lipid nanoparticle around 50 nm in diameter.

3 Mar 2021

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

New research from a team of scientists in Australia finds that the second ‘booster’ dose of the Pfizer-BioNTech vaccine did not increase vaccine efficacy against severe acute respiratory syndrome (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). The results suggest one dose of the vaccine was sufficient in providing a robust immune response 11 days after inoculation.

3 Mar 2021

Report: Probabilistic forecasts of the impact of vaccines and variants on the U.S. COVID trajectory

In a report summary released today Thomas McAndrew, a computational scientist and assistant professor at Lehigh University's College of Health includes probabilistic forecasts of the impact of vaccines and variants on the U.S. COVID trajectory over the next few weeks.

3 Mar 2021

Using two different viruses to tackle tumors

An international research group led by the University of Basel has developed a promising strategy for therapeutic cancer vaccines.

3 Mar 2021

Researchers to investigate COVID-19's disproportionate impact on long-term care residents and workers

Long-term care facilities have been disproportionately burdened by COVID-19, accounting for about 60% of COVID-19 deaths nationwide, 70% if retirement homes are included.

3 Mar 2021

Vaccine candidate shows promise to protect against dozen-plus flu strains

Ask Eric Weaver about pandemics, and he's quick to remind you of a fact that illustrates the fleeting nature of human memory and the proximal nature of human attention: The first pandemic of the 21st century struck not in 2019, but 2009.

3 Mar 2021

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

A team of UK scientists has recently evaluated the effectiveness of the Pfizer (BNT162b2) and AstraZeneca (ChAdOx1) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The findings reveal that both vaccines are effective in significantly reducing SARS-CoV-2 infection in older adults and providing long-term protection.

3 Mar 2021

Obesity may reduce COVID-19 vaccine efficacy, say researchers

A startling indicates that obesity may reduce the immune response to the current COVID-19 vaccines, along with other factors like age and sex. This could have significant implications for vaccination strategies in obese people.

3 Mar 2021

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

An interesting new preprint shows that even if countries are forced to delay the second dose of the current vaccines administered against SARS-CoV-2, to arrest the ongoing COVID-19 pandemic, the cumulative mortality would still fall significantly.

3 Mar 2021

Vaccine News and Research

Latest Vaccine News and Research

Cell surface marker CD47 may allow early diagnosis of severe COVID-19

Researchers detect vaccine-induced SARS-CoV-2 antibodies in breast milk

Reopening of long-term care facilities is ‘an absolute necessity for our well-being’

Coronavirus deranges the immune system in complex and deadly ways

To help farmworkers get Covid tests and vaccine, build trust and a safety net

Accidentally trashed, thawed or expired: reports of Covid vaccine spoilage

Research looks at COVID vaccine hesitancy and refusal among the U.S. public

Mask wearing, physical distancing can prevent spikes in COVID-19 cases during vaccine distribution

Researchers call for more awareness relating to delayed skin reactions to Moderna COVID-19 vaccine

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

Report: Probabilistic forecasts of the impact of vaccines and variants on the U.S. COVID trajectory

Using two different viruses to tackle tumors

Researchers to investigate COVID-19's disproportionate impact on long-term care residents and workers

Vaccine candidate shows promise to protect against dozen-plus flu strains

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

Obesity may reduce COVID-19 vaccine efficacy, say researchers

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in